Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma
Status:
Active, not recruiting
Trial end date:
2022-05-24
Target enrollment:
Participant gender:
Summary
Primary Objective:
To evaluate the efficacy of dupilumab in patients with persistent asthma
Secondary Objectives:
- To evaluate the safety and tolerability of dupilumab
- To evaluate the effect of dupilumab on improving patient reported outcomes including
health related quality of life
- To evaluate dupilumab systemic exposure and immunogenicity